These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 29534065)
81. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564 [TBL] [Abstract][Full Text] [Related]
82. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients. Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876 [TBL] [Abstract][Full Text] [Related]
83. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347 [TBL] [Abstract][Full Text] [Related]
84. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Motawi TM; Sadik NA; Shaker OG; Ghaleb MH Tumour Biol; 2016 Jul; 37(7):9865-74. PubMed ID: 26812693 [TBL] [Abstract][Full Text] [Related]
85. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Ali HEA; Abdel Hameed R; Effat H; Ahmed EK; Atef AA; Sharawi SK; Ali M; Abd Elmageed ZY; Abdel Wahab AH Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e51-e62. PubMed ID: 28750770 [TBL] [Abstract][Full Text] [Related]
86. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma. ALrefai AA; Rizk SK; Khamis AK; Kasemy ZA; Habieb MSE Lab Med; 2024 May; 55(3):310-319. PubMed ID: 37695165 [TBL] [Abstract][Full Text] [Related]
87. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816 [TBL] [Abstract][Full Text] [Related]
88. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710 [TBL] [Abstract][Full Text] [Related]
89. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14. Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355 [TBL] [Abstract][Full Text] [Related]
90. Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma. Wan Y; Cui R; Gu J; Zhang X; Xiang X; Liu C; Qu K; Lin T Oxid Med Cell Longev; 2017; 2017():5189138. PubMed ID: 28811864 [TBL] [Abstract][Full Text] [Related]
91. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways. Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650 [TBL] [Abstract][Full Text] [Related]
92. Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma. Wang YL; Chen CM; Wang XM; Wang L Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):51-6. PubMed ID: 26186881 [TBL] [Abstract][Full Text] [Related]
93. Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma. Bharali D; Jebur HB; Baishya D; Kumar S; Sarma MP; Masroor M; Akhter J; Husain SA; Kar P Asian Pac J Cancer Prev; 2018 Sep; 19(9):2561-2568. PubMed ID: 30256056 [TBL] [Abstract][Full Text] [Related]
94. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
95. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma. Yin J; Hou P; Wu Z; Wang T; Nie Y Tumour Biol; 2015 Jun; 36(6):4501-7. PubMed ID: 25618599 [TBL] [Abstract][Full Text] [Related]
96. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes]. Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154 [TBL] [Abstract][Full Text] [Related]
97. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. Karatas OF; Suer I; Yuceturk B; Yilmaz M; Oz B; Guven G; Cansiz H; Creighton CJ; Ittmann M; Ozen M BMC Cancer; 2016 Nov; 16(1):853. PubMed ID: 27816053 [TBL] [Abstract][Full Text] [Related]
98. Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. Shen J; Wang A; Wang Q; Gurvich I; Siegel AB; Remotti H; Santella RM Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2364-73. PubMed ID: 24127413 [TBL] [Abstract][Full Text] [Related]
99. MicroRNA 125a-5p Inhibits Cell Proliferation and Induces Apoptosis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Downregulation of ErbB3. Li G; Zhang W; Gong L; Huang X Oncol Res; 2019 Mar; 27(4):449-458. PubMed ID: 28800792 [TBL] [Abstract][Full Text] [Related]